Chris Li, PhD

Head of Biology
ByteDance AI Drug Discovery / Anew Therapeutics, United States

Disclosure information not submitted.

Presentation(s):

• First Oral Small-molecule Inhibitors Designed by Generative AI Achieve Biologics-Like Pan-Inhibition of IL-17AA, AF, and FF Dimers

  Thursday, April 16, 2026
  1:30 PM - 1:45 PM US ET